LSV Asset Management
CORT icon

LSV Asset Management’s Corcept Therapeutics CORT Stock Holding History

LSV Asset Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,163
Closed -$158K – 873
2022
Q3 		$158K Sell
6,163
-1,714
-22% -$45.9K ﹤0.01% 807
2022
Q2 		$187K Sell
7,877
-1,629
-17% -$35.5K ﹤0.01% 811
2022
Q1 		$214K Sell
9,506
-28,190
-75% -$600K ﹤0.01% 823
2021
Q4 		$746K Sell
37,696
-36,304
-49% -$736K ﹤0.01% 734
2021
Q3 		$1.46M Sell
74,000
-174,100
-70% -$3.64M ﹤0.01% 674
2021
Q2 		$5.46M Sell
248,100
-145,800
-37% -$3.24M 0.01% 549
2021
Q1 		$9.37M Sell
393,900
-326,500
-45% -$8.72M 0.02% 480
2020
Q4 		$18.8M Sell
720,400
-864,500
-55% -$18.2M 0.03% 376
2020
Q3 		$27.6M Sell
1,584,900
-55,181
-3% -$879K 0.06% 291
2020
Q2 		$27.6M Sell
1,640,081
-243,543
-13% -$3.42M 0.06% 302
2020
Q1 		$22.4M Buy
1,883,624
+165,200
+10% +$2.04M 0.05% 286
2019
Q4 		$20.8M Buy
1,718,424
+629,038
+58% +$8.76M 0.03% 375
2019
Q3 		$15.4M Buy
1,089,386
+534,286
+96% +$6.57M 0.03% 408
2019
Q2 		$6.19M Buy
555,100
+442,200
+392% +$4.93M 0.01% 531
2019
Q1 		$1.32M Hold
112,900
– – ﹤0.01% 727
2018
Q4 		$1.51M Buy
+112,900
New +$1.49M ﹤0.01% 729

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LSV Asset Management's CORT Position: Q4 2022 in Review

LSV Asset Management sold out of Corcept Therapeutics (CORT) in Q4 2022, closing a stake of 6,163 shares — an estimated $158K sold.

LSV Asset Management first reported a position in CORT in Q4 2018 and held it in 16 quarters. The position peaked at $27.6M in Q2 2020. 243 funds tracked by Wall St. Rank hold CORT as of Q4 2022.

  • LSV Asset Management reported no remaining Corcept Therapeutics position as of Q4 2022 after selling out during the quarter.
  • LSV Asset Management sold 6,163 Corcept Therapeutics shares in Q4 2022, an estimated $158K.
  • LSV Asset Management first reported a position in Corcept Therapeutics in Q4 2018 and held it in 16 quarters.
  • LSV Asset Management's Corcept Therapeutics position peaked at $27.6M in Q2 2020.
  • 243 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2022.

Based on LSV Asset Management's 13F filing for Q4 2022, filed 8 Feb 2023.